Healthcare M&A and Valuation
News and Insights

In October 2025, ARCHIMED Diagnostics, the diagnostics-focused arm of global healthcare investment firm ARCHIMED, completed its acquisition of a 60% majority stake in ARK Diagnostics, Inc., a Fremont, California-based developer and manufacturer of specialty in vitro diagnostic (IVD) assays and tests, from South Korean specialty chemical company Soulbrain Holdings. The transaction values ARK at approximately $428 million enterprise value, with Soulbrain retaining a 40% minorit

On October 21, 2025, Hologic, Inc., a leading global medical technology company focused on women’s health diagnostics, imaging and surgical products, agreed to be acquired by funds managed by private equity firms Blackstone and TPG in a take‑private transaction valued at up to $18.3 billion in enterprise value. Under the definitive merger agreement, Hologic stockholders will receive $76 per share in cash plus a non‑tradable contingent value right (CVR) of up to $3 per share,

On October 2, 2025, New Enterprise Associates (NEA) completed a take private transaction involving NeueHealth, Inc., a provider of value-based care solutions that integrates patient engagement, care coordination, and provider enablement tools aimed at improving clinical outcomes and reducing total cost of care. NeueHealth’s platform partners with provider organizations and payors to deliver risk-bearing care models, leveraging data analytics, technology-driven workflows, an

On September29, 2025, Ambac Financial Group, a specialty financial services company focused on insurance, reinsurance, and related risk-based products, announced its acquisition of ArmadaCare, a provider of comprehensive home care and personal support services serving aging and medically complex populations. ArmadaCare’s offering includes non-medical personal care, companion support, and community-based assistance tailored to seniors and individuals with functional limitati

On September 26, 2025, dentalcorp Holdings Ltd. (TSX: DNTL), Canada’s largest dental service organization (DSO), entered into a definitive arrangement agreement to be acquired by investment funds affiliated with private equity firm GTCR in an all‑cash take‑private transaction valued at approximately C$2.2 billion on an equity basis and C$3.3 billion on an enterprise value basis, or roughly $2.4 billion USD. The acquisition deepens GTCR’s presence in the dental services and m

On September 22, 2025, Premier, Inc. a Charlotte‑based, technology‑driven healthcare improvement company specializing in supply chain solutions, data analytics, consulting and collaborative services for hospitals, health systems and other providers, agreed to be acquired by an affiliate of dedicated healthcare investment firm Patient Square Capital in a take‑private transaction valued at approximately $2.6 billion. Under the terms of the deal, Premier stockholders are receiv

On September 23, 2025, Privia Health Group, Inc. (Nasdaq: PRVA) entered into a definitive agreement to acquire the Accountable Care Organization (ACO) business of Evolent Health, Inc. (NYSE: EVH), operating under the Evolent Care Partners (ECP) brand. The transaction provides Privia with more than 120,000 attributed lives across the Medicare Shared Savings Program (MSSP) as well as various commercial and Medicare Advantage programs, expanding Privia’s total value‑based care

On September 16, 2025, Strata Critical Medical, Inc. (Nasdaq: SRTA) announced the acquisition of Keystone Perfusion Services LLC, a leading provider of organ recovery and normothermic regional perfusion (NRP) services, in a transaction valued at approximately $124 million in upfront consideration. The purchase price was paid roughly 88 % in cash and 12 % in Strata common stock, and Strata agreed to additional contingent earn‑outs of up to $23 million tied to future gross pr

On August 15, 2025, Cardinal Health (NYSE: CAH) announced its acquisition of Solaris Health, the leading urology‑focused management services organization (MSO) in the U.S., in a strategic transaction valued at approximately $1.9 billion in cash consideration, with additional equity rollover bringing implied total deal value closer to $2.4 billion. The deal expands Cardinal’s multi‑specialty MSO platform, The Specialty Alliance, by adding more than 750 providers across 250+

The hospice industry plays a critical role in the U.S. healthcare system, providing compassionate, end-of-life care to patients with terminal illnesses. Hospice services include pain management, symptom relief, counseling, and support for both patients and their families. The industry is heavily regulated and deeply influenced by reimbursement policy, but it continues to be a highly active sector for M&A, driven by demographic tailwinds and the ongoing aging of the U.S. popul

On August 1, 2025, ATI Physical Therapy, Inc. (OTC: ATIP), a leading U.S. provider of outpatient physical therapy and rehabilitation services operating hundreds of clinics across more than 20 states, transitioned from a publicly traded company to private ownership through a merger led by existing stockholders and private investment firms Knighthead Capital Management and Marathon Asset Management. Under the definitive merger agreement, stockholders not affiliated with the in

In July 2025, Aurobindo Pharma USA Inc., the wholly owned U.S. subsidiary of Indian generics manufacturer Aurobindo Pharma Ltd., entered into a definitive agreement to acquire Lannett Co., Inc., a U.S. based producer of complex generic pharmaceuticals, for an enterprise value of approximately $250 million on a cash‑free, debt‑free basis. The transaction, which is expected to close within 8–12 months pending regulatory approvals, will provide Aurobindo with full ownership of

The primary care industry serves as the cornerstone of the healthcare system, providing essential, first-contact medical services to individuals and families across a wide range of demographics. Primary care physicians (PCPs), including family practitioners, internists, pediatricians, and geriatricians, focus on preventive care, chronic disease management, and acute illness treatment. The industry is increasingly shifting toward value-based care models, driven by healthcare r

The home health sector is one of the largest areas of post-acute healthcare, with volume growth driven by both demographic pressures and patient preference for care in the home. Services range from skilled nursing and therapy delivered under a physician’s order (medical home health) to non-medical assistance with activities of daily living such as bathing, dressing, and meal preparation (personal care). While both segments share common growth drivers, their operating models,

The ambulatory surgery center (ASC) industry has experienced significant growth over the past decade, driven by the shift toward...

The dermatology industry is a fast-growing sector within the broader healthcare market, driven by increasing demand for both medical and cosmetic dermatological services, as well as service line expansion into aesthetic dermatology and the med spa / wellness category. Medical dermatology focuses on the diagnosis and treatment of skin conditions such as acne, eczema, psoriasis, and skin cancer, while cosmetic dermatology includes procedures like Botox, fillers, laser treatment

The diagnostic imaging center industry is a critical component of the healthcare sector, providing essential services for the detection, diagnosis, and monitoring of various medical conditions. These facilities utilize advanced imaging technologies such as X-rays, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Positron Emission Tomography (PET) to produce detailed images of the body’s internal structures. The industry has seen significant growth o

On June 2, 2025, Ascension Health Alliance, one of the largest nonprofit Catholic health systems in the U.S., entered into a definitive agreement to acquire AmSurg, a leading ambulatory surgery center (ASC) developer, manager and operator that owns and partners with more than 250 outpatient surgery centers across 34 states. The all‑cash transaction, reported by multiple industry sources at approximately $3.9 billion in enterprise value, will significantly expand Ascension’s

On May 30, 2025, The Graph Group , a New Jersey-based healthcare investment firm, announced the acquisition of the acute and intermediate behavioral health services division of Seaside Health System of Baton Rouge , a long-standing inpatient psychiatric provider in Louisiana. Seaside Health System, part of the broader Seaside Healthcare platform backed by Pharos Capital Group, operates a licensed psychiatric facility offering 24/7 inpatient psychiatric stabilization and part

On May 28, 2025, global alternative asset manager Brookfield Asset Management, alongside Caisse de dépôt et placement du Québec (CDPQ), announced the acquisition of GTCR’s Antylia Scientific, a U.S.-based integrated provider of scientific research tools, laboratory services and specialty instruments serving biopharma, diagnostics and academic markets. Antylia’s platform combines branded products, custom solutions, and technical services that address complex laboratory needs